본문

  1. Home
351 Results:PP:ELSEVIER B V 0.203 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
331
Male-female differences in the association between incident hip fracture and proximal femoral strength: A finite element analysis study
Male-female differences in the association between incident hip fracture and proximal femoral strength: A finite element analysis study
Keyak, J. H., | Elsevier Inc | 2011 ,
332
Computational finite element bone mechanics accurately predicts mechanical competence in the human radius of an elderly population
Computational finite element bone mechanics accurately predicts mechanical competence in the human radius of an elderly population
Mueller, T. L., | Elsevier Inc | 2011 ,
333
Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis
Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis
Kalpakcioglu, B. B., | Elsevier Inc | 2011 ,
334
Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women
Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women
Thompson, K., | Elsevier Inc | 2011 ,
335
Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice
Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice
Sugiyama, T, | Elsevier Inc | 2011 ,
336
Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate
Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate
Allen, M. R., | Elsevier Inc | 2011 ,
337
A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
Plotkin, L. I., | Elsevier Inc | 2011 ,
338
The gunmetal mouse reveals Rab geranylgeranyl transferase to be the major molecular target of phosphonocarboxylate analogues of bisphosphonates
The gunmetal mouse reveals Rab geranylgeranyl transferase to be the major molecular target of phosphonocarboxylate analogues of bisphosphonates
Coxon, F. P., | Elsevier Inc | 2011 ,
339
Safety of bisphosphonates
Safety of bisphosphonates
Pazianas, M., | Elsevier Inc | 2011 ,
340
Bisphosphonates in orthopedic applications
Bisphosphonates in orthopedic applications
Wilkinson, J. M., | Elsevier Inc | 2011 ,
처음이전2930313233343536이후마지막